PL3934624T3 - Kompozycja do stosowania miejscowego i sposoby pomiaru zdolności chłodzącej kompozycji do stosowania miejscowego - Google Patents

Kompozycja do stosowania miejscowego i sposoby pomiaru zdolności chłodzącej kompozycji do stosowania miejscowego

Info

Publication number
PL3934624T3
PL3934624T3 PL20800255.0T PL20800255T PL3934624T3 PL 3934624 T3 PL3934624 T3 PL 3934624T3 PL 20800255 T PL20800255 T PL 20800255T PL 3934624 T3 PL3934624 T3 PL 3934624T3
Authority
PL
Poland
Prior art keywords
topical composition
measuring
methods
cooling ability
topical
Prior art date
Application number
PL20800255.0T
Other languages
English (en)
Inventor
Kenneth William James
James Andrew Provost
Original Assignee
Futura Medical Developments Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73040144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3934624(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB1918039.7A external-priority patent/GB201918039D0/en
Priority claimed from GBGB2015404.3A external-priority patent/GB202015404D0/en
Application filed by Futura Medical Developments Limited filed Critical Futura Medical Developments Limited
Publication of PL3934624T3 publication Critical patent/PL3934624T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/417Imidazole-alkylamines, e.g. histamine, phentolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00Investigating or analyzing materials by the use of thermal means
    • G01N25/20Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
    • G01N25/48Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
    • G01N25/4846Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00Investigating or analyzing materials by the use of thermal means
    • G01N25/56Investigating or analyzing materials by the use of thermal means by investigating moisture content
    • G01N25/58Investigating or analyzing materials by the use of thermal means by investigating moisture content by measuring changes of properties of the material due to heat, cold or expansion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Combustion & Propulsion (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL20800255.0T 2019-12-09 2020-10-22 Kompozycja do stosowania miejscowego i sposoby pomiaru zdolności chłodzącej kompozycji do stosowania miejscowego PL3934624T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1918039.7A GB201918039D0 (en) 2019-12-09 2019-12-09 Topical composition
GBGB2015404.3A GB202015404D0 (en) 2020-09-29 2020-09-29 Topical composition
PCT/GB2020/052660 WO2021116651A1 (en) 2019-12-09 2020-10-22 Topical composition and methods of measuring the cooling abaility of a topical composition

Publications (1)

Publication Number Publication Date
PL3934624T3 true PL3934624T3 (pl) 2024-07-08

Family

ID=73040144

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20800255.0T PL3934624T3 (pl) 2019-12-09 2020-10-22 Kompozycja do stosowania miejscowego i sposoby pomiaru zdolności chłodzącej kompozycji do stosowania miejscowego

Country Status (15)

Country Link
US (2) US12414992B2 (pl)
EP (2) EP4342494A3 (pl)
KR (1) KR20220124712A (pl)
CN (2) CN121796316A (pl)
AU (1) AU2020401440A1 (pl)
BR (1) BR112022011284A2 (pl)
CA (1) CA3160206A1 (pl)
DK (1) DK3934624T3 (pl)
ES (1) ES2978421T3 (pl)
FI (1) FI3934624T3 (pl)
MX (1) MX2022007009A (pl)
PL (1) PL3934624T3 (pl)
PT (1) PT3934624T (pl)
TW (1) TWI896577B (pl)
WO (1) WO2021116651A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119112770B (zh) * 2023-12-27 2025-09-05 江苏澳德智科医疗科技有限公司 一种功能凝胶的制备方法
US12517073B2 (en) * 2024-01-25 2026-01-06 Futura Medical Developments Limited Topical composition testing method and apparatus
GB202402524D0 (en) * 2024-02-22 2024-04-10 Futura Medical Developments Ltd Topical composition
CN118576540A (zh) * 2024-07-30 2024-09-03 杭州启真求实科技有限公司 一种用于男性勃起障碍外用的组合物凝胶及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2716739B2 (ja) * 1988-07-26 1998-02-18 インデナ エス.ピー.エイ 血管運動作用を有する化粧用組成物
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6435710B1 (en) * 1998-08-26 2002-08-20 Fauske & Associates, Inc. Foam detector apparatus and method
US6333039B1 (en) * 1998-09-25 2001-12-25 Gojo Industries, Inc. Opaque skin sanitizing composition
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
GB0602224D0 (en) * 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
RU2342923C1 (ru) * 2007-07-26 2009-01-10 Общество с ограниченной ответственностью "Бентус лаборатории" Дезинфицирующее антисептическое средство для обработки рук с увлажняющим эффектом (варианты)
US20090318510A1 (en) * 2008-06-24 2009-12-24 Glycobiosciences, Inc. Topical drug delivery system
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
WO2010044094A2 (en) 2008-09-03 2010-04-22 Krishna Radharaman Agarwal A topical composition for the treatment of erectile dysfunction
US20140227342A1 (en) 2013-02-08 2014-08-14 Michael Farber Acetylcholinesterase inhibitor composition for sexual use
CA2946568C (en) * 2014-04-21 2020-07-07 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same
GB201609968D0 (en) 2016-06-07 2016-07-20 Futura Medical Dev Ltd Topical pharmaceutical formulation
GB201713160D0 (en) 2017-08-16 2017-09-27 Futura Medical Dev Ltd Topical composition
CR20200630A (es) * 2018-06-01 2021-05-26 Tavanta Therapeutics Hungary Incorporated Sales tópicas de amlodipino para el tratamiento de enfermedades anorrectales

Also Published As

Publication number Publication date
US12576152B2 (en) 2026-03-17
US12414992B2 (en) 2025-09-16
CA3160206A1 (en) 2021-06-17
US20230022570A1 (en) 2023-01-26
ES2978421T3 (es) 2024-09-12
TW202135785A (zh) 2021-10-01
CN121796316A (zh) 2026-04-07
KR20220124712A (ko) 2022-09-14
BR112022011284A2 (pt) 2022-09-06
MX2022007009A (es) 2022-08-25
AU2020401440A1 (en) 2022-06-16
WO2021116651A1 (en) 2021-06-17
CN115003278A (zh) 2022-09-02
DK3934624T3 (da) 2024-06-10
EP4342494A2 (en) 2024-03-27
EP4342494A3 (en) 2024-06-05
US20250352650A1 (en) 2025-11-20
TWI896577B (zh) 2025-09-11
EP3934624B1 (en) 2024-03-13
PT3934624T (pt) 2024-04-23
FI3934624T3 (fi) 2024-05-24
CN115003278B (zh) 2025-12-30
EP3934624A1 (en) 2022-01-12

Similar Documents

Publication Publication Date Title
GB2576389B (en) Refrigerant composition and use thereof
PL3934624T3 (pl) Kompozycja do stosowania miejscowego i sposoby pomiaru zdolności chłodzącej kompozycji do stosowania miejscowego
EP3857963A4 (en) CONFIGURATION AND COORDINATION OF MEASUREMENT DEVIATIONS
ZA202109518B (en) Imidazopyrimidines as eed inhibitors and the use thereof
SG10201913562VA (en) Hsp90 inhibitor oral formulations and related methods
ES3063864T3 (en) Novel compound and application thereof
IL293980B1 (en) New compounds and their use
IL277213A (en) Topical preparation
IL284764A (en) compounds and their uses
IL290325A (en) Biopharmaceutical preparations and related methods
IL280644A (en) Magnesium serine compound and its use
ZA202006347B (en) Anti-inflammatory compound and preparation and use thereof
SG11202102182VA (en) Desiccant composition and use thereof
CA193457S (en) Tape measure
ZA202107655B (en) Topical formulation
IL276783A (en) The composition and pharmaceutical compound containing it
EP3239156A4 (en) Novel group 4 transition metal compound and use of same
EP3937950A4 (en) TOPICAL COMPOSITIONS FOR THERMAL PROTECTION AND METHOD FOR THE PRODUCTION THEREOF
CA191209S (en) Tape measure
CA191211S (en) Tape measure
IL290902B2 (en) Compounds for identifying beta-lactamases and methods of using them
PL4013731T3 (pl) Ulepszona kompozycja na bazie mocznika i metoda jej wytwarzania
PL3860615T3 (pl) Kompozycja doustna zawierająca B-escynę i jej zastosowanie
GB201901413D0 (en) Compositions and their use
CA191210S (en) Tape measure